BR122012015772A2 - - Google Patents

Info

Publication number
BR122012015772A2
BR122012015772A2 BR122012015772A BR122012015772A BR122012015772A2 BR 122012015772 A2 BR122012015772 A2 BR 122012015772A2 BR 122012015772 A BR122012015772 A BR 122012015772A BR 122012015772 A BR122012015772 A BR 122012015772A BR 122012015772 A2 BR122012015772 A2 BR 122012015772A2
Authority
BR
Brazil
Application number
BR122012015772A
Other languages
Portuguese (pt)
Other versions
BR122012015772B8 (pt
BR122012015772A8 (pt
BR122012015772B1 (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2001/001940 external-priority patent/WO2002032900A2/en
Publication of BR122012015772A2 publication Critical patent/BR122012015772A2/pt
Publication of BR122012015772A8 publication Critical patent/BR122012015772A8/pt
Publication of BR122012015772B1 publication Critical patent/BR122012015772B1/pt
Publication of BR122012015772B8 publication Critical patent/BR122012015772B8/pt

Links

BR122012015772A 2000-10-19 2001-10-15 compostos de imidazol fundidos a atila ou heteroarila BR122012015772B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24182500P 2000-10-19 2000-10-19
US60/241,825 2000-10-19
BRPI0114704 2001-10-15
PCT/IB2001/001940 WO2002032900A2 (en) 2000-10-19 2001-10-15 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents

Publications (4)

Publication Number Publication Date
BR122012015772A2 true BR122012015772A2 (el) 2004-02-25
BR122012015772A8 BR122012015772A8 (pt) 2017-10-03
BR122012015772B1 BR122012015772B1 (pt) 2018-05-02
BR122012015772B8 BR122012015772B8 (pt) 2021-05-25

Family

ID=62103641

Family Applications (1)

Application Number Title Priority Date Filing Date
BR122012015772A BR122012015772B8 (pt) 2000-10-19 2001-10-15 compostos de imidazol fundidos a atila ou heteroarila

Country Status (1)

Country Link
BR (1) BR122012015772B8 (el)

Also Published As

Publication number Publication date
BR122012015772B8 (pt) 2021-05-25
BR122012015772A8 (pt) 2017-10-03
BR122012015772B1 (pt) 2018-05-02

Similar Documents

Publication Publication Date Title
BE2017C009I2 (el)
BE2016C059I2 (el)
BE2016C018I2 (el)
BE2013C060I2 (el)
BE2013C048I2 (el)
BE2011C041I2 (el)
BE2010C008I2 (el)
BRPI0113085B8 (el)
AU2000236815A8 (el)
BRPI0110940B8 (el)
BE2014C025I2 (el)
BRPI0113372A8 (el)
BR0112866A2 (el)
BR122012015772A2 (el)
AU2000278679A8 (el)
CN3135488S (el)
AU2000278560A8 (el)
AU2000276986A8 (el)
AU2000276780A8 (el)
AU2000273097A8 (el)
AU2000271150A8 (el)
AU2000270908A8 (el)
AU2000270757A8 (el)
AU2000256695A8 (el)
AU2000256023A8 (el)

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25G Requested change of headquarter approved

Owner name: RAQUALIA PHARMA INC. (JP)

B25A Requested transfer of rights approved

Owner name: RAQUALIA PHARMA INC. (JP)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: ASKAT INC. (JP)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 15/10/2021